API acquisition joust not over yet

Wesfarmers the front runners but Sigma still in the running as takeover battle rumbles on When Wesfarmers bought W.H.Soul Pattinson's 19.3% share of Australian Pharmaceutical Industries (API) in the first week of October, the move was seen as potentially enough to block Sigma's superior offer via the shareholder vote it would give Wesfarmers. But, to